Skin Biopsy Market Growth Expected to Reach $2.73 Billion by 2030 with 8% CAGR

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Skin Biopsy Market Expected To Change Between 2026 And 2030?

The skin biopsy market has shown robust growth over recent years. It is forecast to increase from $1.86 billion in 2025 to $2.02 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.3%. This historical expansion can be attributed to a rise in skin cancer incidence, the proliferation of dermatology clinics, the adoption of outpatient diagnostic methods, the availability of biopsy instruments, and improved awareness of early diagnosis.

The skin biopsy market is anticipated to experience substantial expansion in the coming years, set to reach $2.74 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. This growth during the forecast period is propelled by factors such as a rise in melanoma incidents, the embrace of AI-powered diagnostics, the increasing presence of tele-dermatology, an aging population, and the expansion within cosmetic dermatology. Prominent trends for this period encompass the adoption of minimally invasive biopsy methods, the broadening scope of dermatology diagnostics, a preference for punch and shave biopsy techniques, the shift towards outpatient diagnostic procedures, and the incorporation of AI-assisted pathology.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28330&type=smp

Which Major Factors Are Driving The Expansion Of The Skin Biopsy Market?

An anticipated surge in healthcare spending is poised to drive the expansion of the skin biopsy market in the foreseeable future. Healthcare expenditure encompasses the aggregate financial outlay directed towards medical services, therapies, infrastructure, research, and public health efforts aimed at preserving or elevating health outcomes. This growing demand for healthcare funding stems from the increasing incidence of chronic illnesses, which necessitate prolonged and expensive medical interventions. Greater healthcare spending facilitates the uptake of skin biopsies by improving access to sophisticated diagnostic tools and broadening the scope of dermatology services. This, in turn, allows for prompt detection and precise diagnosis of skin conditions, contributing to superior patient results and enhanced overall healthcare effectiveness. For illustration, the Office for National Statistics, a UK-based government department, reported in May 2024 that the total healthcare expenditure experienced a 5.6% rise in nominal terms during 2023, representing a 0.9% growth compared to 2022. Consequently, the upward trend in healthcare expenditure is a key factor propelling the expansion of the skin biopsy market.

How Is The Skin Biopsy Market Structured Across Different Segments?

The skin biopsy market covered in this report is segmented –

1) By Type Of Biopsy: Excisional Biopsy, Incisional Biopsy, Punch Biopsy, Shave Biopsy

2) By Application: Dermatology, Oncology, Clinical Research

3) By End-User: Hospitals, Ambulatory Surgical Centers (ASCs), Dermatology Clinics

Subsegments:

1) By Excisional Biopsy: Full-Thickness Excision, Elliptical Excision

2) By Incisional Biopsy: Wedge Biopsy, Longitudinal Biopsy, Keyhole Biopsy

3) By Punch Biopsy: 2 Millimeter (mm) Punch, 3-4 Millimeter (mm) Punch, Greater Than Or Equal To (=) 5 Millimeter (mm) Punch

4) By Shave Biopsy: Tangential Shave, Saucerization Shave, Curved Blade Shave

Which Trends Are Shaping The Future Of The Skin Biopsy Market?

Major companies within the skin biopsy market are prioritizing the development of advanced solutions like semi-automatic biopsy instruments to improve diagnostic accuracy and the quality of tissue samples. Semi-automatic biopsy devices are engineered to provide precise and controlled tissue collection, thereby increasing the likelihood of an accurate diagnosis and enabling pathologists to conduct comprehensive testing. For instance, in May 2023, Argon Medical Devices, a U.S.-based provider of interventional and oncology device solutions, introduced its SuperCore Advantage Semi-Automatic Biopsy Instrument. This device delivers enhanced tissue volume and is available in a full range of lengths and gauge sizes to suit various clinical applications. It is a disposable, next-generation product, designed with input from healthcare professionals to address clinical needs. The SuperCore Advantage enables physicians to confidently collect more tissue, supports precise and reliable biopsies, and complements Argon’s existing portfolio, which includes the BioPince Ultra Full Core Biopsy Instrument, SuperCore Semi-Automatic, Tru-Core Automatic, and Pro-Mag Ultra Biopsy Instruments. This addition strengthens Argon’s position as a leading provider of soft tissue biopsy devices while also enhancing outcomes for patients.

Which Major Players Dominate The Skin Biopsy Market?

Major companies operating in the skin biopsy market are AccuTec Inc., Delasco, KAI Medical, Medline Industries, Becton Dickinson and Company, Merit Medical Systems, Cook Medical, Hologic, Olympus Corporation, KARL STORZ, Richard Wolf, ConMed, Integra LifeSciences, Paramount Surgimed, Sklar Instruments, Hu-Friedy, Aesculap, World Precision Instruments, Miltex, Integra Miltex

Read the full skin biopsy market report here:

https://www.thebusinessresearchcompany.com/report/skin-biopsy-global-market-report

Which Region Currently Holds The Largest Share Of The Skin Biopsy Market?

North America was the largest region in the skin biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the skin biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Skin Biopsy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28330&type=smp

Browse Through More Reports Similar to the Global Skin Biopsy Market 2026, By The Business Research Company

Liquid Biopsy Market Report 2026

https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report

Medical Skin Markers Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-skin-markers-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795